The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1
暂无分享,去创建一个
P. Foster | A. Ramsay | M. Rothenberg | I. G. Young | K. Matthaei | A. Mould | I. Young
[1] 久田 剛志. α4 integrin-dependent eotaxin induction of bronchial hyper-responsiveness and eosinophil migration in interleukin-5 transgenic mice , 2000 .
[2] K. Chung,et al. alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice. , 1999, American journal of respiratory cell and molecular biology.
[3] D D Donaldson,et al. Interleukin-13: central mediator of allergic asthma , 1998 .
[4] D B Corry,et al. Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.
[5] R. E. Wiley,et al. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. , 1998, The Journal of clinical investigation.
[6] M. Jordana,et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. , 1998, The Journal of clinical investigation.
[7] P. Foster,et al. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. , 1998, Journal of immunology.
[8] D. Friend,et al. Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Rankin,et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. , 1998, Blood.
[10] J. Gutiérrez-Ramos,et al. Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors. , 1998, Blood.
[11] A. Fryer,et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. , 1997, The Journal of clinical investigation.
[12] S. Rankin,et al. Kinetics of Eotaxin Generation and Its Relationship to Eosinophil Accumulation in Allergic Airways Disease: Analysis in a Guinea Pig Model In Vivo , 1997, The Journal of experimental medicine.
[13] E. Gelfand,et al. Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.
[14] P. Foster,et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.
[15] P. Leder,et al. Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.
[16] E. Pearce,et al. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils , 1996, The Journal of experimental medicine.
[17] A. Kapp,et al. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils , 1996, European journal of immunology.
[18] H. Kita,et al. Chemokines active on eosinophils: potential roles in allergic inflammation , 1996, The Journal of experimental medicine.
[19] M. van de Rijn,et al. Eotaxin Triggers Eosmophil-Selective Chemotaxis and Calcium Flux via a Distinct Receptor and Induces Pulmonary Eosinophilia in the Presence of Interleukin 5 in Mice , 1996, Molecular medicine.
[20] D. Wong,et al. Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. , 1996, Journal of immunology.
[21] R. Egan,et al. Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. , 1996, The American journal of physiology.
[22] P. Foster,et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.
[23] R. Locksley,et al. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [published erratum appears in J Exp Med 1997 May 5;185(9):1715] , 1996, The Journal of experimental medicine.
[24] N. Copeland,et al. Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.
[25] P. Hodgkin,et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.
[26] T. Williams,et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo , 1995, The Journal of experimental medicine.
[27] M C Swanson,et al. Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. , 1995, The Journal of clinical investigation.
[28] M. Seminario,et al. The role of eosinophils in the pathogenesis of asthma. , 1994, Current opinion in immunology.
[29] N. Barnes,et al. Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. , 1994, Thorax.
[30] J. Hsuan,et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation , 1994, The Journal of experimental medicine.
[31] J. Tavernier,et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.
[32] M. Kohonen-Corish,et al. Interleukin‐5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo , 1993, European journal of immunology.
[33] D. Wong,et al. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. , 1993, Journal of immunology.
[34] G. Firestein,et al. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. , 1992, The Journal of clinical investigation.
[35] F. Leyva-Cobián,et al. Eosinophil as antigen‐presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing , 1992, European journal of immunology.
[36] T. Fukuda,et al. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. , 1992, The American review of respiratory disease.
[37] C. Harley,et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). , 1992, The Journal of clinical investigation.
[38] S. Durham,et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.
[39] L. Koenderman,et al. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. , 1992, Blood.
[40] D. Wong,et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. , 1991, Blood.
[41] S. Nourshargh,et al. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. , 1991, Immunology.
[42] F. Luscinskas,et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules , 1991, The Journal of experimental medicine.
[43] A J Wardlaw,et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.
[44] G. Gleich,et al. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. , 1991, The Journal of clinical investigation.
[45] E. Ingley,et al. Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems. , 1991, European journal of biochemistry.
[46] H. Kita,et al. Regulatory effect of cytokines on eosinophil degranulation. , 1990, Journal of immunology.
[47] C. Sanderson,et al. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. , 1989, Blood.
[48] B. Coupar,et al. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes. , 1988, Gene.
[49] N. Flavahan,et al. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. , 1988, The Journal of allergy and clinical immunology.
[50] T. Suda,et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor , 1988, The Journal of experimental medicine.
[51] J. Gamble,et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.
[52] N. Flavahan,et al. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. , 1988, The American review of respiratory disease.
[53] A. Wardlaw,et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.
[54] H. Sluiter,et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.
[55] D. Loegering,et al. Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.
[56] G. Discombe. Criteria of eosinophilia. , 1946, Lancet.